Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 242517, 8 pages
http://dx.doi.org/10.1155/2015/242517
Research Article

NaoXinTong Inhibits the Development of Diabetic Retinopathy in Mice

1State Key Laboratory of Medicinal Chemical Biology, Nankai University, 94 Weijin Road, Tianjin 300071, China
2College of Life Sciences, Nankai University, 94 Weijin Road, Tianjin 300071, China
3College of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, China
4Collaborative Innovation Center for Biotherapy, Nankai University, 94 Weijin Road, Tianjin 300071, China
5Buchang Pharmaceutical Co. Ltd., 50 Gaoxin Road, Xi’an 712000, China
6Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 312 Anshan West Road, Tianjin 300193, China

Received 30 October 2014; Revised 8 December 2014; Accepted 16 December 2014

Academic Editor: Kuzhuvelil B. Harikumar

Copyright © 2015 Mengyang Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. R. Whiting, L. Guariguata, C. Weil, and J. Shaw, “IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030,” Diabetes Research and Clinical Practice, vol. 94, no. 3, pp. 311–321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. R. N. Frank, “Diabetic retinopathy,” The New England Journal of Medicine, vol. 350, no. 1, pp. 48–58, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. B. E. K. Klein, “Overview of epidemiologic studies of diabetic retinopathy,” Ophthalmic Epidemiology, vol. 14, no. 4, pp. 179–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Cheung, P. Mitchell, and T. Y. Wong, “Diabetic retinopathy,” The Lancet, vol. 376, no. 9735, pp. 124–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. D. S. Fong, L. Aiello, T. W. Gardner et al., “Retinopathy in diabetes,” Diabetes Care, vol. 27, supplement 1, pp. S84–S87, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Klein, B. E. K. Klein, S. E. Moss, and K. J. Cruickshanks, “Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy,” Archives of Internal Medicine, vol. 154, no. 19, pp. 2169–2178, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. R. A. Kowluru and P. S. Chan, “Oxidative stress and diabetic retinopathy,” Experimental Diabetes Research, vol. 2007, Article ID 43603, 12 pages, 2007. View at Publisher · View at Google Scholar
  8. J. Tang and T. S. Kern, “Inflammation in diabetic retinopathy,” Progress in Retinal and Eye Research, vol. 30, no. 5, pp. 343–358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S.-I. Yamagishi and T. Matsui, “Advanced glycation end products (AGEs), oxidative stress and diabetic retinopathy,” Current Pharmaceutical Biotechnology, vol. 12, no. 3, pp. 362–368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. D. A. Antonetti, R. Klein, and T. W. Gardner, “Diabetic retinopathy,” The New England Journal of Medicine, vol. 366, no. 13, pp. 1227–1239, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Teuscher, H. Schnell, and P. W. F. Wilson, “Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure,” Diabetes Care, vol. 11, no. 3, pp. 246–251, 1988. View at Publisher · View at Google Scholar · View at Scopus
  12. Diabetes Control and Complications Trial Research Group, “Progression of retinopathy with intensive versus conventional treatment in the diabetes control and complications trial. Diabetes control and complications trial research group,” Ophthalmology, vol. 102, no. 4, pp. 647–661, 1995. View at Publisher · View at Google Scholar
  13. F. Zhang, B. Huang, Y. Zhao et al., “BNC protects H9c2 cardiomyoblasts from H2O2-induced oxidative injury through ERK1/2 signaling pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 802784, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. J. J. Zhao, H. Zhu, S. J. Wang et al., “Naoxintong protects against atherosclerosis through lipid-lowering and inhibiting maturation of dendritic cells in LDL receptor knockout mice fed a high-fat diet,” Current Pharmaceutical Design, vol. 19, no. 33, pp. 5891–5896, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Chen, Y. Zhang, X. Wu, C. Li, and H. Wang, “In vitro assessment of cytochrome P450 2C19 potential of naoxintong,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 430262, 6 pages, 2012. View at Publisher · View at Google Scholar
  16. W. R. Bell, W. R. Green, and M. F. Goldberg, “Histopathologic and trypsin digestion studies of the retina in incontinentia pigmenti,” Ophthalmology, vol. 115, no. 5, pp. 893–897, 2008. View at Google Scholar · View at Scopus
  17. R. A. Feit-Leichman, R. Kinouchi, M. Takeda et al., “Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes,” Investigative Ophthalmology & Visual Science, vol. 46, no. 11, pp. 4281–4287, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Chen, M. Liu, T. Zhao et al., “Danhong injection inhibits the development of atherosclerosis in both apoe-/- and Ldlr-/- mice,” Journal of Cardiovascular Pharmacology, vol. 63, no. 5, pp. 441–452, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Miwa, J. Nakamura, Y. Hamada et al., “The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes,” Diabetes Research and Clinical Practice, vol. 60, no. 1, pp. 1–9, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Behl, P. Krothapalli, T. Desta, A. DiPiazza, S. Roy, and D. T. Graves, “Diabetes-enhanced tumor necrosis factor-α production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy,” American Journal of Pathology, vol. 172, no. 5, pp. 1411–1418, 2008. View at Google Scholar · View at Scopus
  21. G. Mohammad and R. A. Kowluru, “Diabetic retinopathy and signaling mechanism for activation of matrix metalloproteinase-9,” Journal of Cellular Physiology, vol. 227, no. 3, pp. 1052–1061, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Mohammad and R. A. Kowluru, “Novel role of mitochondrial matrix metalloproteinase-2 in the development of diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 52, no. 6, pp. 3832–3841, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. W. Y. Yau, S. L. Rogers, R. Kawasaki et al., “Global prevalence and major risk factors of diabetic retinopathy,” Diabetes Care, vol. 35, no. 3, pp. 556–564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Roy, D. Das, K. Saurabh et al., “Role of hyperglycemia-mediated erythrocyte redox state alteration in the development of diabetic retinopathy,” Retina, vol. 33, no. 7, pp. 1480–1481, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Choudhuri, D. Dutta, I. H. Chowdhury et al., “Association of hyperglycemia mediated increased advanced glycation and erythrocyte antioxidant enzyme activity in different stages of diabetic retinopathy,” Diabetes Research and Clinical Practice, vol. 100, no. 3, pp. 376–384, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. G. L. King, “Hyperglycemia and the pathogenesis of diabetic retinopathy,” Journal of General Internal Medicine, vol. 1, no. 2, pp. 133–134, 1986. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Brownlee, “The pathobiology of diabetic complications: a unifying mechanism,” Diabetes, vol. 54, no. 6, pp. 1615–1625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. A. M. Joussen, V. Poulaki, M. L. Le et al., “A central role for inflammation in the pathogenesis of diabetic retinopathy,” The FASEB Journal, vol. 18, no. 12, pp. 1450–1452, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. R. A. Kowluru, J. Tang, and T. S. Kern, “Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy,” Diabetes, vol. 50, no. 8, pp. 1938–1942, 2001. View at Google Scholar · View at Scopus